Related Experiment Videos
Managing systemic symptoms in chronic liver disease
Julia L Newton1, David E J Jones
1UK NIHR Biomedical Research Centre in Ageing and Age Related Diseases, Newcastle University, Newcastle, UK. j.l.newton@ncl.ac.uk
Journal of Hepatology
|February 4, 2012
Summary
Patients with chronic liver disease (CLD) increasingly live with the condition, experiencing systemic symptoms like fatigue and cognitive issues impacting quality of life. A structured management approach is crucial for improving patient outcomes in CLD.
Area of Science:
- Hepatology
- Internal Medicine
- Clinical Research
Background:
- Chronic liver disease (CLD) management has improved, shifting focus from mortality to patient longevity.
- Systemic symptoms, not just end-stage liver disease consequences, significantly impair quality of life in CLD patients.
- Fatigue, sleep disturbance, autonomic dysfunction, and cognitive issues are common systemic symptoms in CLD.
Purpose of the Study:
- To review the current understanding of systemic symptoms in chronic liver disease.
- To offer recommendations for the successful management of these debilitating symptoms.
- To highlight the potential for shared pathogenetic processes and common management strategies across different CLDs.
Main Methods:
- Literature review of systemic symptoms in chronic liver disease.
- Analysis of symptom presentation, including fatigue, autonomic dysfunction, and cognitive impairment.
- Examination of management strategies, particularly in primary biliary cirrhosis.
Main Results:
- Systemic symptoms in CLD are often unrelated to liver disease severity.
- Fatigue, sleep disturbance, and autonomic dysfunction are characteristic, affecting blood pressure regulation.
- Cognitive symptoms and falls can occur, even in non-cirrhotic patients.
- Structured management strategies have shown promise in improving quality of life.
Conclusions:
- Systemic symptoms significantly impact CLD patients' functional ability and quality of life.
- A systematic, structured approach addressing all contributing factors is critical for effective management.
- Further research into shared pathogenetic processes may lead to common management strategies for various CLDs.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...